Capecitabine, oxaliplatin, radiotherapy, and excision (CORE) in patients with MRI-defined locally advanced rectal adenocarcinoma: Results of an international multicenter phase II studyH.J.T. Rutten, Philip Quirke, Marc Peeters et al.|Journal of Clinical Oncology|2006Cited by 74